Red Drugs Policy
Over the past decade, there has been a significant increase in the use of painkillers and sedative medications prescribed for conditions such as chronic pain, back pain, and fibromyalgia. This increase was often based on recommendations from hospitals and pain clinics. Medications such as morphine, MST, co-codamol, tramadol, dihydrocodeine, oxycodone, pregabalin, gabapentin, temazepam, diazepam, nitrazepam, and zopiclone were prescribed in high doses, in combination, and for long-term use. Many patients were assured that when used in this manner, these medications would not lead to addiction or dependence.
However, the medical profession now acknowledges that this approach was misguided. These medications are indeed dependence-forming and can cause withdrawal symptoms when attempts are made to discontinue them. Over time, individuals may develop tolerance, meaning the medications become less effective, yet they continue to be taken in order to maintain functioning. Long-term use of these medications is associated with poor health outcomes, including accidents, cognitive impairment, and even death. In the United States alone, over 40,000 deaths annually are attributed to these medications, which has led to their classification as part of an epidemic and a public health crisis.
As a result, many individuals now find themselves inadvertently addicted and dependent on these medications. The positive news is that it is possible to reduce or even stop their use, and many individuals report feeling significantly better after doing so. If you require support or advice, please do not hesitate to contact us.
Please note that our policy does not permit the initiation or increase of certain medications, often referred to as “Red Drugs,” which include:
- Morphine
- MST
- Co-codamol
- Co-Dydramol
- Tramadol
- Dihydrocodeine
- Oxycodone
- Pregabalin
- Gabapentin
- Temazepam
- Diazepam
- Nitrazepam
- Zopiclone